Status | Study |
Completed |
Study Name: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia Condition: Choroidal Neovascularization Myopia, Degenerative Date: 2011-08-22 Interventions: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Completed |
Study Name: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen Condition: Choroidal Neovascularisation Date: 2009-12-21 Interventions: Drug: ranibizumab 0.5mg |
Completed |
Study Name: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization Condition: Myopic Choroidal Neovascularization Date: 2008-11-24 Interventions: Drug: Injection Intravitreal injection of 1.25 mg bevacizumab |
Completed |
Study Name: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) Condition: Choroidal Neovascularization Date: 2007-08-01 Interventions: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye |
Completed |
Study Name: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Condition: Macular Degeneration Choroidal Neovascularization Date: 2007-02-16 Interventions: Drug: Verteporfin Photodynamic Therapy |
Terminated |
Study Name: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) Condition: Macular Degeneration Choroidal Neovascularization Date: 2007-02-08 Interventions: Drug: Verteporfin Photodynamic Therapy |
Completed |
Study Name: Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization Condition: Subfoveal Choroidal Neovascularization Date: 2006-12-01 Interventions: Drug: intravitreal injection of ranibizumab |
Withdrawn |
Study Name: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Condition: Choroidal Neovascularization Date: 2006-11-22 Interventions: Drug: Imatinib Mesylate /Ranibizumab |
Completed |
Study Name: Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. Condition: Choroidal Neovascularization Date: 2006-11-01 Interventions: Drug: ranibizumab 0.5mg intravitreal injection |
Completed |
Study Name: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Condition: Choroidal Neovascularization, Age-related Macular Degeneration Date: 2006-09-21 Interventions: Drug: Ranibizumab 0.5 mg Ranibizumab intravitreal injection 0.5 mg in a single-dose regimen given on an |